Viewing Study NCT00144261


Ignite Creation Date: 2025-12-24 @ 12:07 PM
Ignite Modification Date: 2025-12-28 @ 8:19 AM
Study NCT ID: NCT00144261
Status: COMPLETED
Last Update Posted: 2025-01-31
First Post: 2005-09-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-label, Non-randomized, Single-arm Study to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma HDL in HIV+ Subjects
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module